Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis.
Open Forum Infect Dis
; 9(9): ofac440, 2022 Sep.
Article
en En
| MEDLINE
| ID: mdl-36172057
ABSTRACT
Patients with multidrug-resistant tuberculosis who received regimens containing high-dose isoniazid (INHHD) had similar time to culture conversion and treatment outcomes as patients who received regimens with bedaquiline. INHHD is an inexpensive and safe medication that may contribute additive efficacy in combination regimens.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Open Forum Infect Dis
Año:
2022
Tipo del documento:
Article
País de afiliación:
Estados Unidos